Publication date: May 10, 2019
Maeda, T., Yoshino, K., Nagai, K., Oaku, S., Kato, M., Hiura, A., and Hata, H. Development of endocrine immune-related adverse events and improved survival in advanced melanoma patients treated with nivolumab monotherapy. 22634. 2019 Eur J Cancer (115):
|Survival advanced melanoma|
- Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.